Eli Lilly becomes first pharma major to enter $1 trillion M-Cap club; stock price rises 1.7% on Wall St.
United States-based drugmaker Eli Lilly on 21 November 2025, became the first pharmaceutical company and only the second non-technology firm, to enter the trillion-dollar market capitalisation club after its stock…
Lilly launches Mounjaro KwikPen in India
Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…
Lilly Opens Hyderabad Digital Innovation Center to Boost Research
Anuj Batra New Delhi, August 5, 2025 — In a major boost to India’s health-tech ecosystem, Eli Lilly and Company has inaugurated a 220,000 square foot global digital innovation centre…
India’s anti-obesity drug market quadruples in five years on lifestyle disease surge
India’s anti-obesity drug market has grown more than fourfold in the last five years fuelled by rising instances of lifestyle diseases along with greater affordability and willingness among a section…
Popular diabetes drug, Mounjaro, launched in India
Mounjaro (tirzepatide): A breakthrough drug for the treatment of Type 2 diabetes and obesity, has been released in India. The drug has been approved by the Central Drugs Standard Control Organization…
Pharma companies turn to AI to speed up drug development, but hit hurdles
When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals, its scientists thought they had a future lung medicine in their hands. Artificial intelligence came up with another plan. It was…
